Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8(+) and CD4(+) T-cell responses with multiple specificities including a novel D...

por Baumgaertner, P., Costa Nunes, C., Cachot, A., Maby-El Hajjami, H., Cagnon, L., Braun, M., Derré, L., Rivals, J.-P., Rimoldi, D., Gnjatic, S., Abed Maillard, S., Marcos Mondéjar, P., Protti, M. P., Romano, E., Michielin, O., Romero, P., Speiser, D. E., Jandus, C.
Publicado en Oncoimmunology (2016)